file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
| Word(i) List (4568) Word count: 24159, All words count: 34321 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 1601 | DIABETIC-PATIENTS | 3 | 5 | 81 |
| 1602 | DIETHYLAMINOETHYL | 1 | 5 | 12 |
| 1603 | DIFFICULTY | 1 | 5 | 5 |
| 1604 | DISAPPEARANCE | 1 | 5 | 76 |
| 1605 | DISCONTINUATION | 1 | 5 | 73 |
| 1606 | DONOR-AND | 2 | 5 | 36 |
| 1607 | DOUBLE | 1 | 5 | 20 |
| 1608 | ELIMINATING | 1 | 5 | 5 |
| 1609 | ENDOGENOUS | 4 | 5 | 521 |
| 1610 | EPISTEMOLOGIC | 1 | 5 | 5 |
| 1611 | EPSTEIN-BARR | 4 | 5 | 133 |
| 1612 | ESTABLISH | 3 | 5 | 23 |
| 1613 | EX-VIVO | 2 | 5 | 38 |
| 1614 | EXIST | 1 | 5 | 14 |
| 1615 | FACILITATING | 2 | 5 | 18 |
| 1616 | FLAP | 2 | 5 | 17 |
| 1617 | FLT3L-TREATED | 1 | 5 | 10 |
| 1618 | FREEDOM | 1 | 5 | 19 |
| 1619 | GAMMA-DELTA | 1 | 5 | 63 |
| 1620 | GETS | 1 | 5 | 7 |
| 1621 | GOOD | 2 | 5 | 25 |
| 1622 | HAIR-GROWTH | 1 | 5 | 42 |
| 1623 | HELPER | 2 | 5 | 33 |
| 1624 | HEMODYNAMIC-EFFECTS | 1 | 5 | 5 |
| 1625 | HETEROLOGUE | 1 | 5 | 23 |
| 1626 | HISTOCOMPATIBLE | 1 | 5 | 58 |
| 1627 | HISTOLOGIC | 1 | 5 | 18 |
| 1628 | HOST-CELL-MEDIATED | 1 | 5 | 7 |
| 1629 | IMMUNOGLOBULIN | 5 | 5 | 78 |
| 1630 | IMMUNOHISTOLOGICAL | 1 | 5 | 27 |
| # | Word | Recs | TLCS | TGCS |
| 1631 | INTERMITTENT | 1 | 5 | 76 |
| 1632 | INTERSTITIAL | 3 | 5 | 71 |
| 1633 | INTRAVENOUSLY | 1 | 5 | 76 |
| 1634 | ISOZYMES | 1 | 5 | 35 |
| 1635 | IWTH | 1 | 5 | 20 |
| 1636 | LAPAROSCOPY | 1 | 5 | 21 |
| 1637 | LIGHT-MICROSCOPIC | 1 | 5 | 94 |
| 1638 | LIQUID-CHROMATOGRAPHY | 5 | 5 | 64 |
| 1639 | LIVER-ASSOCIATED | 1 | 5 | 18 |
| 1640 | LUPUS | 6 | 5 | 198 |
| 1641 | MAINTAIN | 3 | 5 | 16 |
| 1642 | MICRODISSECTION | 2 | 5 | 77 |
| 1643 | MONONUCLEAR-CELLS | 1 | 5 | 19 |
| 1644 | MONTH | 1 | 5 | 13 |
| 1645 | MYELOID | 5 | 5 | 34 |
| 1646 | NATURE | 3 | 5 | 52 |
| 1647 | NEPHROTIC | 3 | 5 | 20 |
| 1648 | NEUROPROTECTIVE | 6 | 5 | 99 |
| 1649 | NEUROREGENERATIVE | 2 | 5 | 60 |
| 1650 | NEUTROPHILS | 4 | 5 | 85 |
| 1651 | NEWLY | 4 | 5 | 61 |
| 1652 | NONPARENCHYMAL | 2 | 5 | 9 |
| 1653 | NOTES | 2 | 5 | 41 |
| 1654 | NVA2-CYCLOSPORINE | 1 | 5 | 33 |
| 1655 | OBTAINING | 1 | 5 | 23 |
| 1656 | OLD | 2 | 5 | 18 |
| 1657 | ONGOING | 5 | 5 | 73 |
| 1658 | OSTEOMYOCUTANEOUS | 2 | 5 | 17 |
| 1659 | PARADOX | 1 | 5 | 10 |
| 1660 | PARENTHOOD | 2 | 5 | 221 |
| # | Word | Recs | TLCS | TGCS |
| 1661 | PEPTIC-ULCER | 2 | 5 | 53 |
| 1662 | PERFUSATE | 1 | 5 | 18 |
| 1663 | PIGS | 7 | 5 | 52 |
| 1664 | PITFALLS | 3 | 5 | 59 |
| 1665 | POLAR | 1 | 5 | 34 |
| 1666 | POLICIES | 1 | 5 | 15 |
| 1667 | POPULATIONS | 4 | 5 | 34 |
| 1668 | POTASSIUM | 2 | 5 | 63 |
| 1669 | PREDICTORS | 3 | 5 | 19 |
| 1670 | PRETRANSPLANTATION | 1 | 5 | 21 |
| 1671 | PREVENT | 3 | 5 | 50 |
| 1672 | PROCEDURES | 2 | 5 | 46 |
| 1673 | PROGRAMMED | 2 | 5 | 40 |
| 1674 | QUALITIES | 1 | 5 | 19 |
| 1675 | RABBITS | 4 | 5 | 90 |
| 1676 | RATES | 3 | 5 | 84 |
| 1677 | REAPPRAISAL | 2 | 5 | 17 |
| 1678 | RENAL-HOMOTRANSPLANT | 1 | 5 | 87 |
| 1679 | ROSETTE | 1 | 5 | 14 |
| 1680 | RUPTURE | 4 | 5 | 86 |
| 1681 | SECRETION | 5 | 5 | 217 |
| 1682 | SEGMENTAL | 2 | 5 | 74 |
| 1683 | SENIORS | 1 | 5 | 30 |
| 1684 | SERUMS | 1 | 5 | 23 |
| 1685 | SKIN-GRAFTS | 1 | 5 | 63 |
| 1686 | SOLUTE | 1 | 5 | 22 |
| 1687 | SPLENIC | 3 | 5 | 47 |
| 1688 | STR-ANALYSIS | 1 | 5 | 71 |
| 1689 | SURFACE | 4 | 5 | 55 |
| 1690 | SWITCH | 1 | 5 | 10 |
| # | Word | Recs | TLCS | TGCS |
| 1691 | THROMBOEMBOLIC | 3 | 5 | 61 |
| 1692 | TRANSIENTLY | 1 | 5 | 16 |
| 1693 | TRANSPLANT-RELATED | 1 | 5 | 18 |
| 1694 | TRIUMPH | 2 | 5 | 14 |
| 1695 | ULTRASTRUCTURE | 2 | 5 | 45 |
| 1696 | UTILITY | 2 | 5 | 102 |
| 1697 | VENUE | 1 | 5 | 16 |
| 1698 | WHITE | 6 | 5 | 108 |
| 1699 | WITHDRAWN | 1 | 5 | 14 |
| 1700 | 1-YEAR | 1 | 4 | 86 |
| 1701 | ACCUMULATION | 2 | 4 | 67 |
| 1702 | ADDITIONAL | 2 | 4 | 9 |
| 1703 | ALLO-AND | 3 | 4 | 14 |
| 1704 | ALLOANTIBODY | 2 | 4 | 17 |
| 1705 | ALLOSUPPRESSIVE | 1 | 4 | 20 |
| 1706 | ALLOTRANSPLANTED | 2 | 4 | 34 |
| 1707 | AMERICAN | 1 | 4 | 16 |
| 1708 | ANTILUMPHOCYTE | 1 | 4 | 23 |
| 1709 | ANTIMOUSE | 2 | 4 | 48 |
| 1710 | APPARATUS | 1 | 4 | 8 |
| 1711 | APPROACHES | 9 | 4 | 220 |
| 1712 | APPROACHING | 2 | 4 | 12 |
| 1713 | AUSTRALIA | 2 | 4 | 47 |
| 1714 | BIOCHEMICAL | 4 | 4 | 50 |
| 1715 | BIOLOGIC | 1 | 4 | 8 |
| 1716 | CALCINEURIN-MEDIATED | 1 | 4 | 64 |
| 1717 | CAMPATH-1M | 2 | 4 | 43 |
| 1718 | CD25 | 3 | 4 | 37 |
| 1719 | CELL-FREE | 2 | 4 | 37 |
| 1720 | CHANGING | 6 | 4 | 49 |
| # | Word | Recs | TLCS | TGCS |
| 1721 | CHOLANGITIS | 2 | 4 | 90 |
| 1722 | CIRCULATE | 1 | 4 | 20 |
| 1723 | CLINICAL-RESULTS | 3 | 4 | 76 |
| 1724 | CLOTRIMAZOLE | 2 | 4 | 28 |
| 1725 | COLONY-STIMULATION | 2 | 4 | 10 |
| 1726 | CONCOMITANT | 2 | 4 | 40 |
| 1727 | CONTROLLED-STUDY | 1 | 4 | 8 |
| 1728 | CONTROVERSIES | 1 | 4 | 40 |
| 1729 | COROLLARIES | 1 | 4 | 9 |
| 1730 | CORTICOSTEROIDS | 7 | 4 | 46 |
| 1731 | CROSS-SPECIES | 1 | 4 | 475 |
| 1732 | CTL | 1 | 4 | 13 |
| 1733 | DAUGHTER | 1 | 4 | 22 |
| 1734 | DERIVED | 1 | 4 | 6 |
| 1735 | DETACH | 1 | 4 | 20 |
| 1736 | DETERMINANT | 3 | 4 | 137 |
| 1737 | DEVELOPED | 3 | 4 | 43 |
| 1738 | DISPARATE | 1 | 4 | 21 |
| 1739 | DIURESIS | 2 | 4 | 27 |
| 1740 | DONER | 1 | 4 | 4 |
| 1741 | DUAL | 1 | 4 | 28 |
| 1742 | EBV-SPECIFIC | 1 | 4 | 13 |
| 1743 | ERYTHEMATOSUS | 5 | 4 | 182 |
| 1744 | ERYTHREMIA | 1 | 4 | 55 |
| 1745 | EXPANSION | 4 | 4 | 42 |
| 1746 | EXPLORATION | 1 | 4 | 68 |
| 1747 | FACILITATES | 3 | 4 | 21 |
| 1748 | FACTS | 2 | 4 | 6 |
| 1749 | FIBROBLASTS | 1 | 4 | 34 |
| 1750 | FORMAL | 1 | 4 | 68 |
| # | Word | Recs | TLCS | TGCS |
| 1751 | FULL | 2 | 4 | 23 |
| 1752 | FUNCTIONAL-DIFFERENTIATION | 1 | 4 | 30 |
| 1753 | GENERATION | 8 | 4 | 94 |
| 1754 | GLOBULIN-RELATED | 1 | 4 | 8 |
| 1755 | GRAFT-REJECTION | 1 | 4 | 21 |
| 1756 | GREEN | 3 | 4 | 55 |
| 1757 | GUINEA | 2 | 4 | 30 |
| 1758 | H-2-DISPARATE | 1 | 4 | 14 |
| 1759 | HEMATOLOGICAL | 2 | 4 | 16 |
| 1760 | HIGH-PERFORMANCE | 5 | 4 | 115 |
| 1761 | HISTOPATHOLOGICAL | 5 | 4 | 85 |
| 1762 | HLA-MATCHED | 2 | 4 | 63 |
| 1763 | IMMUNODEPRESSIVE | 3 | 4 | 22 |
| 1764 | IMMUNOLOGICALLY | 1 | 4 | 40 |
| 1765 | IMMUNOTHERAPEUTIC | 2 | 4 | 89 |
| 1766 | IMPLANTATION | 3 | 4 | 23 |
| 1767 | INTERFERING | 2 | 4 | 30 |
| 1768 | INTERINDIVIDUAL | 1 | 4 | 154 |
| 1769 | INTERPRETATION | 2 | 4 | 75 |
| 1770 | INTRAHEPATIC | 1 | 4 | 104 |
| 1771 | IRON | 1 | 4 | 25 |
| 1772 | JAPANESE | 3 | 4 | 25 |
| 1773 | JAUNDICE | 1 | 4 | 66 |
| 1774 | JUXTAGLOMERULAR | 1 | 4 | 8 |
| 1775 | KIDNEY-MORPHOLOGICAL | 1 | 4 | 8 |
| 1776 | KUPFFER | 4 | 4 | 18 |
| 1777 | LECTURE | 3 | 4 | 117 |
| 1778 | LEUCOCYTE | 3 | 4 | 21 |
| 1779 | LIGAND-MOBILIZED | 1 | 4 | 20 |
| 1780 | LONG-LIVED | 1 | 4 | 6 |
| # | Word | Recs | TLCS | TGCS |
| 1781 | MACROLACTAMIZATION | 1 | 4 | 68 |
| 1782 | MALFUNCTION | 1 | 4 | 26 |
| 1783 | MATRICES | 1 | 4 | 22 |
| 1784 | METHODOLOGY | 1 | 4 | 8 |
| 1785 | MIZORIBINE | 1 | 4 | 31 |
| 1786 | MMF | 1 | 4 | 86 |
| 1787 | MODIFICATION | 7 | 4 | 77 |
| 1788 | MONO-DRUG | 1 | 4 | 19 |
| 1789 | MRNA | 2 | 4 | 47 |
| 1790 | NETWORK | 3 | 4 | 36 |
| 1791 | NONIMMUNOLOGICALLY | 1 | 4 | 66 |
| 1792 | NONSURGICAL | 1 | 4 | 65 |
| 1793 | NONVASCULARIZED | 1 | 4 | 12 |
| 1794 | OPINIONS | 1 | 4 | 68 |
| 1795 | ORTHOCLONE | 2 | 4 | 74 |
| 1796 | P450 | 1 | 4 | 154 |
| 1797 | PATHOLOGICAL | 2 | 4 | 121 |
| 1798 | PHARMACOKINETIC | 3 | 4 | 86 |
| 1799 | PHASE-II | 1 | 4 | 23 |
| 1800 | POST-TRANSPLANTATION | 4 | 4 | 69 |